• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulatory mechanism of T cell immune response mediaed by CD26 and ganglioside GD3

Research Project

Project/Area Number 14570406
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionThe University of Tokyo

Principal Investigator

HOSONO Osamu  The University of Tokyo, Institute of Medical Science, Reserch Assistant, 医科学研究所, 助手 (50190210)

Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥1,600,000 (Direct Cost: ¥1,600,000)
KeywordsCD26 / ganglioside / T cells / immune response / Caveolin / dipeptidylpeptidase IV / Caveolin-1 / dipeptidyl peptidase IV
Research Abstract

CD26 and ganglioside GD3 are preferentially expressed on memory T cell migration and activation. Regulatory mechanism of T cell immune response mediated by CD26 and ganglioside GD3 was studied in this research.
1.Novel CD26 associated molecule: Novel CD26 binding protein was eluted from cell lysate of monocyte-derived cell line. THP-1, and was determined as caveolin-1. Scaffolding domain of caveolin-1 was required for binding to CD26. Caveolin-1 was expressed on the surface of monocytes after antigen stimulation and could enhance the expression of CD86 on monocytes through binding to soluble CD26.
2.Analysis of enhanced transendothelial migratory activity of CD26 and GD3 positive T cells: CD26 positive T cells could transmigrate after adhesion to the endothelial cells through LFA-1. In addition, GD3 positive T cells could spontaneously transmigrate through interaction between GD3 and some molecules on the surface of endothelial cells. In lymphocytes with enhanced expression of CD26 and GD3, Cas-L (Crk-associated substrate lymphcyte type) expression and phosphorylaton were augumented. These results indicated that Cas-L play a critical role in transendothelial migratory activity of CD26 and GD3 strongly positive T cells.
3.Regulation of T cell function by antibodies against CD26 and GD3: Cross-linking by anti-CD26antibody could increase CD26 molecule in the raft and induce tyrosine phosphorylation of c-Cbl, ZAP70, ERK1/2, and TCRζ. Binding of the soluble anti-CD26 antibody could inhibit T cell growth by inducing GI/S arrest, which is associatd with enhancement of p21^<Cipl> iexpression. Anti-GD3 antibody induced apoptosis of some GD3 positive cells. GD3 was co-localized wih lyn and caveolin-1, not with ganglioside GM1 in rafts recognized by cholera toxin B (CTB).

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (19 results)

All Other

All Publications (19 results)

  • [Publications] Hisakawa N.: "Aberrant responsiveness to RANTES in synovial fluid T cells from patients with rheumatoid arthritis."Journal of Rheumatology. 29. 1124-1134 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kobayashi H.: "Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in patients with systemic lupus erythematosus."Journal of Rheumatology. 29. 1858-1866 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ohnuma K.: "G1/S cell cycle arrest provoked in human T cells by antibody to CD26."Immunology. 107. 325-333 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miyake-Nishijima R.: "Role of Crk-associated sub state lymphocyte type in pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans."Arthritis Rheum. 48. 1890-1900 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nori M.: "Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines."Clin Exp Allergy. 33. 1544-1554 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hosono O.: "CD26: a key molecule in immune regulation and autoimmune diseases."Mod Rheumatol. 13. 199-204 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hisakawa N, et al.: "A berrant responsiveness to RANTES in synovial fluid T cells from patients with rheumatoid arthritis."J Rheumatol. 29(6). 1124-1134 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kobayashi H, et al.: "Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with desease activity in systemic lupus erythematosus"J Rheumatol. 29(9). 1858-1866 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ohnuma K, et al.: "G1/S cell cycle arrest provoked in human T cells by antibody to CD26"Immunology. 107(3). 325-333 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miyake-NIshijima R, et al.: "Role of Crk-associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans."Arthritis Rheum. 48(7). 1890-1900 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nori M, et al.: "Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines."Clin Exp Allergy. 33(11). 1544-1554 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hosono O, et al.: "CD26: a key molecule in immune regulation and autoimmune diseases"Mod Rheumatol. 13(3). 199-204 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miyake-Nishijima R., et al.: "Role of Crk-associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans."Arthritis Rheum. 48(7). 1890-1900 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nori M., et al.: "Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory {cytokines}."Clin Exp Allergy. 33(11). 1544-1554 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hosono O., et al.: "CD26: a key molecule in immune regulation and autoimmune diseases."Mod Rheumatol. 13(3). 199-204 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hisakawa N.: "Aberrant responsiveness to RANTES in synovial fluid T cells from patients with rheumatoid arthritis"Journal of Rheumatology. 29(6). 1124-1134 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kobayashi H.: "Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in patients with systemic lupus erythematosus"Journal of Rheumatology. 29(9). 1858-1866 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ohnuma K.: "G1/S cell cycle arrest provoked in human T cells by antibody to CD26"Immunology. 107(3). 325-333 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hosono O.: "CD26: a key molecule in immune regulation and autoimmune diseases"Modern Rheumatology. (in press).

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi